Northern Trust Corp Grows Position in Nextgen Healthcare Inc (NXGN)

Northern Trust Corp grew its holdings in Nextgen Healthcare Inc (NASDAQ:NXGN) by 1.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 680,106 shares of the company’s stock after acquiring an additional 10,056 shares during the period. Northern Trust Corp owned about 1.05% of Nextgen Healthcare worth $10,305,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also made changes to their positions in NXGN. PNC Financial Services Group Inc. increased its holdings in shares of Nextgen Healthcare by 37.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 2,387 shares of the company’s stock worth $36,000 after purchasing an additional 649 shares during the last quarter. Comerica Bank increased its holdings in shares of Nextgen Healthcare by 1.4% in the fourth quarter. Comerica Bank now owns 47,000 shares of the company’s stock worth $813,000 after purchasing an additional 665 shares during the last quarter. O Shaughnessy Asset Management LLC increased its holdings in shares of Nextgen Healthcare by 3.2% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 43,381 shares of the company’s stock worth $658,000 after purchasing an additional 1,356 shares during the last quarter. Texas Permanent School Fund increased its holdings in shares of Nextgen Healthcare by 4.7% in the fourth quarter. Texas Permanent School Fund now owns 31,315 shares of the company’s stock worth $474,000 after purchasing an additional 1,415 shares during the last quarter. Finally, Quantamental Technologies LLC bought a new stake in shares of Nextgen Healthcare in the fourth quarter worth about $60,000. Institutional investors and hedge funds own 71.55% of the company’s stock.

Several equities research analysts have recently issued reports on the company. Zacks Investment Research raised Nextgen Healthcare from a “hold” rating to a “buy” rating and set a $21.00 target price on the stock in a report on Friday, April 26th. Svb Leerink raised Nextgen Healthcare from a “market perform” rating to an “outperform” rating and boosted their price objective for the stock from $19.00 to $22.00 in a research note on Thursday, April 25th. Leerink Swann raised Nextgen Healthcare from a “market perform” rating to an “outperform” rating in a research note on Thursday, April 25th. Finally, Dougherty & Co raised Nextgen Healthcare from a “neutral” rating to a “buy” rating and set a $19.00 price objective on the stock in a research note on Friday, January 11th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $19.50.

Shares of NASDAQ:NXGN traded up $0.51 during trading hours on Friday, hitting $19.75. 267,215 shares of the company’s stock traded hands, compared to its average volume of 235,268. Nextgen Healthcare Inc has a 1 year low of $13.27 and a 1 year high of $23.73. The firm has a market capitalization of $1.22 billion, a PE ratio of 34.65, a price-to-earnings-growth ratio of 3.13 and a beta of 1.18. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.32 and a quick ratio of 1.31.

TRADEMARK VIOLATION WARNING: “Northern Trust Corp Grows Position in Nextgen Healthcare Inc (NXGN)” was reported by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this article on another domain, it was illegally copied and republished in violation of international copyright legislation. The correct version of this article can be accessed at https://www.baseballdailydigest.com/news/2019/05/04/nextgen-healthcare-inc-nxgn-shares-bought-by-northern-trust-corp.html.

About Nextgen Healthcare

NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.

Further Reading: Is a Roth IRA right for you?

Institutional Ownership by Quarter for Nextgen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.